EUVIMEDEUVIMED entdecken
Open Access

Longitudinal Dynamics of Plasma Neurofilament Light Chain in Hereditary Spastic Paraplegia Type 11 ( HSP ‐ SPG11 ) and Type 15 ( HSP ‐ ZFYVE26 )

Habibah A P Agianda iD, Julian E Alecu, Amy Tam, Hyo-Min Kim, Joshua Rong iD, Nicole Battaglia, Kaitlyn Warren, Rebekah Mannix, Nunzio Setola, Melissa Barghigiani, Grace Yoon, Yoshihisa Takiyama und 6 weitere

Movement Disorders · 2025

DOI: 10.1002/mds.70142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Habibah A P Agianda und 17 weiteren Autor:innen. Beteiligte Einrichtung: Movement Disorders Program, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Spastic Paraplegia, Hereditary, Neurofilament Proteins. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, EURO-HSP, Spastic Paraplegia Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

HSP‐ SPG11 and HSP‐ ZFYVE26 are autosomal‐recessive forms of hereditary spastic paraplegias (HSPs). As therapeutic trials emerge, validated biomarkers are critically needed.

Objectives

To evaluate plasma neurofilament light chain (pNfL) as a biomarker for neurodegeneration and disease progression.

Methods

We analyzed pNfL levels in 57 patients (36 HSP‐ SPG11 , 21 HSP‐ ZFYVE26 ) and matched controls using single‐molecule array technology. Longitudinal clinical and biomarker data were collected over 5 years.

Results

Baseline pNfL levels were significantly elevated in patients: 33.85 pg/mL (IQR 25.15–47.38) in HSP‐ SPG11 , 46.70 pg/mL (IQR 29.95–54.84) in HSP‐ ZFYVE26 , and 4.90 pg/mL (IQR 3.48–6.90) in controls ( P < 0.001). No significant difference was observed between HSP‐ SPG11 and HSP‐ ZFYVE26 . In matched pair analysis, pNfL showed inverse correlation with age (ρ = −0.463, P < 0.001). Baseline pNfL did not predict future clinical progression.

Conclusions

Elevated pNfL reflects early neuroaxonal injury in HSP‐ SPG11 and HSP‐ ZFYVE26 ; however, it could not be used as a surrogate for disease progression. © 2025 International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spastic Paraplegia, HereditaryNeurofilament ProteinsHumansMaleFemaleAdultLongitudinal StudiesBiomarkersDisease ProgressionMiddle AgedYoung AdultAdolescentProteins

Stichwörter der Autor:innen

axonal degenerationbiomarkerhereditary spastic paralysisneurofilament light chainspasticity

Substanzen

Neurofilament Proteinsneurofilament protein LBiomarkersSPG11 protein, humanProteins

Autor:innen und Institutionen

  • Movement Disorders Program, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Emergency Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, IRCCS Stella Maris Foundation, Pisa, Italy.
  • Division of Clinical and Metabolic Genetics, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Department of Neurology, Fuefuki Central Hospital, Yamanashi, Japan.
  • Department of Genomic Medicine, Department of Neurology, Seoul National University Hospital, Seoul, South Korea.

ORCID-Profile: Habibah A P Agianda, Joshua Rong, Jangsup Moon, Kathryn Yang, Filippo Maria Santorelli, Darius Ebrahimi-Fakhari

Förderung

  • NINDS NIH HHS
  • EURO-HSP
  • Spastic Paraplegia Foundation
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Agianda, H. A. P., Alecu, J. E., Tam, A., Kim, H. M., Rong, J., Battaglia, N., Warren, K., Mannix, R., Setola, N., Barghigiani, M., Yoon, G., Takiyama, Y., Moon, J., Bernardi, K., Yang, K., Schierbaum, L., Santorelli, F. M., & Ebrahimi-Fakhari, D. (2025). Longitudinal Dynamics of Plasma Neurofilament Light Chain in Hereditary Spastic Paraplegia Type 11 ( HSP ‐ SPG11 ) and Type 15 ( HSP ‐ ZFYVE26 ). Movement Disorders. https://doi.org/10.1002/mds.70142

Vancouver

Agianda HAP, Alecu JE, Tam A, Kim HM, Rong J, Battaglia N, et al. Longitudinal Dynamics of Plasma Neurofilament Light Chain in Hereditary Spastic Paraplegia Type 11 ( HSP ‐ SPG11 ) and Type 15 ( HSP ‐ ZFYVE26 ). Movement Disorders. 2025. doi:10.1002/mds.70142

BibTeX
@article{Agianda2025,
  author = {Agianda, Habibah A P and Alecu, Julian E and Tam, Amy and Kim, Hyo-Min and Rong, Joshua and Battaglia, Nicole and Warren, Kaitlyn and Mannix, Rebekah and Setola, Nunzio and Barghigiani, Melissa and Yoon, Grace and Takiyama, Yoshihisa and Moon, Jangsup and Bernardi, Katerina and Yang, Kathryn and Schierbaum, Luca and Santorelli, Filippo Maria and Ebrahimi-Fakhari, Darius},
  title = {Longitudinal Dynamics of Plasma Neurofilament Light Chain in Hereditary Spastic Paraplegia Type 11 ( HSP ‐ SPG11 ) and Type 15 ( HSP ‐ ZFYVE26 )},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.70142}
}
Kostenlos starten →